Literature DB >> 7461018

The use of marker drugs to measure organ function: a theoretical interpretation.

J Cobby, M C Makoid.   

Abstract

An equation is presented which describes the changes in drug clearance through an isolated organ due to alterations in the blood flow to the organ or the intrinsic clearance of the drug by the organ. In the case of hepatic clearance, example calculations of alterations in both parameters are presented from literature data for marker drugs having high and low extraction ratios. The predicted hepatic clearance of d-propranolol based on these calculations compares with observed values. For the particular example of the kidney, the blood flow and the intrinsic clearance change in proportion and, therefore, yield a simple equation relating renal clearance of any drug to endogenous creatinine clearance. This equation, though used clinically, has previously not been derived theoretically.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7461018     DOI: 10.1007/bf00874665

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  Hepatic uptake and biliary excretion of indocyanine green in the dog.

Authors:  H O WHEELER; W I CRANSTON; J I MELTZER
Journal:  Proc Soc Exp Biol Med       Date:  1958-10

3.  Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males.

Authors:  D F DAVIES; N W SHOCK
Journal:  J Clin Invest       Date:  1950-05       Impact factor: 14.808

4.  Clearance concepts in pharmacokinetics.

Authors:  M Rowland; L Z Benet; G G Graham
Journal:  J Pharmacokinet Biopharm       Date:  1973-04

5.  The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration.

Authors:  A J Wood; D M Kornhauser; G R Wilkinson; D G Shand; R A Branch
Journal:  Clin Pharmacokinet       Date:  1978 Nov-Dec       Impact factor: 6.447

6.  Mechanism for reduced drug clearance in patients with cirrhosis.

Authors:  D Pessayre; D Lebrec; V Descatoire; M Peignoux; J P Benhamou
Journal:  Gastroenterology       Date:  1978-03       Impact factor: 22.682

7.  Determination of drug metabolizing enzymes in needle biopsies of human liver.

Authors:  B Schoene; R A Fleischmann; H Remmer; H F von Oldershausen
Journal:  Eur J Clin Pharmacol       Date:  1972-03       Impact factor: 2.953

8.  Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance.

Authors:  K S Pang; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1977-12

Review 9.  Renal failure, drug pharmacokinetics and drug action.

Authors:  J Fabre; L Balant
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

10.  Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.

Authors:  R A Branch; D G Shand; G R Wilkinson; A S Nies
Journal:  J Clin Invest       Date:  1974-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.